ESPAÑOL
|
ENGLISH
Home
Company
Healthcare Professionals
Patients
CSR
Career
HOME > PRESS
Comunicados de Prensa
Suscribe to alerts service
En esta sección puede descargarse información general sobre PharmaMar.
Para cualquier consulta adicional, puede contactar con el departamento de comunicación: + 34 91 846 6000.
Kit de prensa
YONDELIS jpg 1,08 Mb
Pharmamar logo jpg 304 Kb
Corporate brochure pdf 4.83 Mb
Corporate presentation pdf 3.08 Mb
NEWS
Yondelis® granted 8 new approvals outside the EEA
2010-2-3
Yondelis® receives positive recommendation from the UK’s NICE for the treatment of advanced soft tissue sarcoma
2009-12-21
PharmaMar presents new results with Yondelis®, Zalypsis® and Irvalec® at AACR-NCI-EORTC 21st international conference
2009-11-27
European Commission authorises the sale of Yondelis® for ovarian cancer
2009-11-2
More news
Zeltia Group
Investors
Press
Site Map
Contact
Copyright ©2010 Pharmamar. All
rights reserved
.